Crossmark

Small-intestinal TG2-specific plasma cells at different stages of coeliac disease

Crossref DOI link: https://doi.org/10.1186/s12865-018-0275-7

Published Online: 2018-12-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hietikko, Minna

Koskinen, Outi

Kurppa, Kalle

Laurila, Kaija

Saavalainen, Päivi

Salmi, Teea

Ilus, Tuire

Huhtala, Heini

Kaukinen, Katri

Lindfors, Katri http://orcid.org/0000-0001-7417-5151
Funding

Funding for this research was provided by:

Academy of Finland (-)

Suomen Lääketieteen Säätiö (-)

Research Fund of the Finnish Celiac Society (-)

Sigrid Juséliuksen Säätiö (-)

Lastentautien Tutkimussäätiö (-)

Competitive State Research Financing of the Expert Area of Tampere University Hospital (-)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 31 August 2018

Accepted: 27 November 2018

First Online: 6 December 2018

Ethics approval and consent to participate

: The study protocol was approved by the Ethics Committee of the Pirkanmaa Hospital District, Tampere, Finland, and written informed consent was obtained from all participating subjects.

: Not applicable.

: All authors have read the journal’s policy on the disclosure of potential conflicts of interest and have none to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.